The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from India

Reasoning

The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from India

Cite this ruling

CBP Ruling N292241 (3004200060): The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from India

Paste this into a product's override reason when citing this ruling as justification for a classification.

Other rulings for HS6 300420